Toxicology and Epigenetics 2012
DOI: 10.1002/9781118349045.ch28
|View full text |Cite
|
Sign up to set email alerts
|

Bioinformatics for High‐Throughput Toxico‐Epigenomics Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 93 publications
0
3
0
Order By: Relevance
“…More likely factors for malignant progression in the Cancer Genetics HPV-positive group include the accumulation of confined chromosomal alterations, such as extra copies of chromosome 3q found in HPV-positive uterine cervical cancers and TSCC, [39][40][41] deletion of 16q, 40,41 and/or modification of the methylation status of the host cell DNA. 42,43 In addition, molecular alterations underlying lymphangiogenesis and epithelial mesenchymal transition might contribute to malignant tumor progression in these cases. 44,45 Because most HPV-positive TSCCs are genomically stable, it could be expected that also their associated precursor lesions show this feature.…”
Section: Discussionmentioning
confidence: 99%
“…More likely factors for malignant progression in the Cancer Genetics HPV-positive group include the accumulation of confined chromosomal alterations, such as extra copies of chromosome 3q found in HPV-positive uterine cervical cancers and TSCC, [39][40][41] deletion of 16q, 40,41 and/or modification of the methylation status of the host cell DNA. 42,43 In addition, molecular alterations underlying lymphangiogenesis and epithelial mesenchymal transition might contribute to malignant tumor progression in these cases. 44,45 Because most HPV-positive TSCCs are genomically stable, it could be expected that also their associated precursor lesions show this feature.…”
Section: Discussionmentioning
confidence: 99%
“…As a result, it's critical to explore current trends, possible uses, and anticipated constraints that researchers are encountering when incorporating epigenetic data into human health assessment models. Toxicoepigenomics has the potential to meet critical demands in both science and applied toxicology [9].…”
Section: Current Trends In Toxicoepigenomics Researchmentioning
confidence: 99%
“…We applied one such tool, LRpath, to identify common pathways dysregulated via DNA methylation across cancer types (44). For a review of the available sequencing technologies and bioinformatics methods for performing, analyzing, and interpreting epigenomics studies, as well as integrative approaches for understanding the epigenetics in the context of the genome and transcriptome, see Sartor et al (82). …”
Section: Introductionmentioning
confidence: 99%